-
CF Candidate Therapy ELX-02 Shows Positive Results in Early Trials
163Phase 1 studies in healthy people and preclinical work indicate that Eloxx Pharmaceuticals’ candidate therapy ELX-02 may help to treat cystic fibrosis. Click here to read more about it.
What are your thoughts about this news?
Sorry, there were no replies found.
Log in to reply.